ArticleCureus2022

The Oncotype DX Recurrence Score's Impact on the Management of Oestrogen-Positive/Human Epidermal Growth Factor Receptor 2-Negative, Low-Burden Axillary Status Breast Cancer (REHAB Study): Results of a Single Centre.

Abdalla Saad Abdalla Al-Zawi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.